Study Finds ‘Forever Chemicals’ Tied to Increased Multiple Sclerosis Risk

Lead

A Sweden-based research team reports a new association between long-lasting industrial compounds and multiple sclerosis (MS). Published in Environment International, the analysis compared blood samples from 900 people recently diagnosed with MS against samples from people without the disease and found that higher levels of perfluorooctane sulfonic acid (PFOS) and certain polychlorinated biphenyl (PCB) breakdown products were linked to increased odds of MS. Individuals with the highest concentrations of PFOS and PCBs had roughly twice the odds of an MS diagnosis compared with those with the lowest concentrations. The investigators also observed an interaction between a specific genetic variant and PFOS exposure, suggesting complex gene–environment effects.

Key Takeaways

• The study analyzed blood samples from 900 recently diagnosed MS patients and matched controls to measure chemical concentrations and disease association.
• Researchers examined combined exposures and found that increasing total chemical burden was associated with higher MS odds after adjusting for known lifestyle and genetic risk factors.
• A particular inherited gene variant that typically reduces MS risk showed an unexpected increase in MS odds when carriers had higher PFOS levels.
• PFOS and PCBs persist in people and the environment; PCBs were banned in the U.S. in 1979, while PFAS (including PFOS-related compounds) remain in many consumer products.
• The authors emphasize the need to study chemical mixtures rather than single substances, reflecting real-world co-exposures.

Background

Per- and polyfluoroalkyl substances (PFAS), often called “forever chemicals,” and polychlorinated biphenyls (PCBs) are synthetic compounds with long environmental and biological half-lives. PFAS are used in items such as non-stick cookware, waterproof fabrics and food packaging; PCBs were widely used for decades before regulatory bans but remain detectable in soil, water and food chains. Both classes have been linked in prior research to cancer, liver and kidney disease, immune effects and reproductive issues, prompting sustained public-health concern.

Multiple sclerosis is a chronic autoimmune disorder in which the immune system attacks the myelin sheath of nerve fibers, disrupting communication between the brain and body and causing symptoms such as numbness, weakness, gait disturbance and visual changes. MS etiology is multifactorial: inherited susceptibility, smoking, vitamin D status and past infections are established contributors, but environmental toxicants have been increasingly investigated for potential roles in triggering or modulating risk.

Main Event

The investigators measured concentrations of PFOS, PCBs and related metabolites in blood samples from 900 people recently diagnosed with MS and compared them with samples from people without MS. Using regression models that adjusted for known lifestyle and genetic risk factors, the team quantified associations between individual chemicals, summed exposures and odds of MS. Several individual compounds, notably PFOS and two hydroxylated PCB species, were associated with higher odds of MS; the strongest comparisons showed approximately double the odds in the highest versus lowest exposure groups.

The researchers also created combined-exposure metrics to reflect real-world co-exposures; these composite measures showed a positive relationship with MS odds, meaning people with higher overall burdens of the chemicals tended to have higher likelihoods of an MS diagnosis. Analyses accounted for established covariates but the authors note that residual confounding cannot be entirely excluded. The study team described their approach as a step toward evaluating chemical mixtures rather than isolated agents.

A further phase of the work evaluated interaction between genetic predisposition and chemical exposure. The team reported that carriers of a particular gene variant, which otherwise appears to confer a lower risk of MS, exhibited unexpectedly higher odds of MS when PFOS levels were elevated. The authors framed this as evidence of a complex interplay between heredity and environmental exposure that merits deeper mechanistic investigation.

Analysis & Implications

This study adds to a growing literature linking persistent organic pollutants to autoimmune and neurological outcomes, though it does not establish causation. Observational designs can identify associations and suggest hypotheses, but they cannot by themselves prove that PFOS or PCBs cause MS. Confounding by unmeasured factors and reverse causation (disease state influencing chemical levels) remain methodological considerations, even when investigators adjust for many known risk factors.

The roughly twofold association observed for the highest exposure groups is epidemiologically notable and, if replicated, could have public-health significance given the lifelong nature of MS and the ubiquity of PFAS exposure. Regulation and exposure-reduction strategies for PFAS are already expanding in many jurisdictions; linking these chemicals to additional chronic conditions could accelerate policy and consumer-level responses.

The reported gene–exposure interaction underscores that population-level risk is heterogeneous: genetic background may modify how environmental toxicants influence disease processes. That complexity complicates risk communication and regulatory decision-making because protective measures that reduce average population exposure may have variable impacts across genetic subgroups.

Comparison & Data

The table summarizes the principal numerical findings reported: individual PFOS and certain hydroxylated PCBs showed the strongest associations, near a twofold difference between exposure extremes. The study emphasized mixture effects because people are exposed to multiple compounds simultaneously; the summed-exposure metric retained an association with MS after statistical adjustment. While the magnitude here is meaningful for epidemiology, translating odds ratios into public-health impact requires prevalence, exposure-distribution and causal confirmation.

Reactions & Quotes

“We saw that several individual substances, such as PFOS and two hydroxylated PCBs, were linked to increased odds for MS,”

Kim Kultima (study lead, Sweden)

The lead researcher summarized the core association between specific compounds and MS odds while noting the need for further study to establish mechanisms.

“An increase in total exposure was linked to higher odds of MS, even after adjusting for previously known lifestyle and genetic risk factors,”

Aina Vaivade (first author, study)

The first author highlighted that combined exposures—reflecting real-world chemical mixtures—remained associated with MS risk in adjusted models.

“MS causes interruption in communication between the brain and the rest of the body and can eventually lead to permanent nerve damage,”

Mayo Clinic (medical reference)

Mayo Clinic provides clinical context for why an environmental contribution to MS risk would carry long-term implications for affected individuals.

Unconfirmed

• Causation: The study is observational and cannot prove that PFOS or PCBs cause MS rather than being correlated with other causal factors.
• Mechanism: The biological pathways linking PFAS or PCB metabolites to MS onset remain unproven and require laboratory and longitudinal investigation.
• Gene–exposure specifics: The reported interaction with a protective gene variant needs replication and functional validation before clinical interpretation.
• Control-group details: Public summaries do not specify all matching criteria for controls, leaving potential for residual confounding.

Bottom Line

The research offers evidence that higher blood levels of PFOS and certain PCB metabolites are associated with greater odds of a multiple sclerosis diagnosis, and that combined chemical burdens and genetic background may modify that association. While the reported associations—approximately twofold in the highest exposure groups—are epidemiologically important, they do not establish causality and must be interpreted with caution until replicated and extended by mechanistic studies.

For policymakers and clinicians, the study reinforces the rationale for reducing population exposure to persistent organic pollutants and for prioritizing research on how mixtures and genetics jointly influence chronic disease risk. For the public, pragmatic steps to limit PFAS exposure—such as reducing use of certain non-stick and waterproofed products and staying informed about local contamination—may be warranted while scientists pursue definitive answers.

Sources

• AOL / People article on the study (news media summary)
• Environment International (peer-reviewed journal — study published there)
• Mayo Clinic — Multiple Sclerosis overview (medical reference)
• U.S. Environmental Protection Agency — PCBs (government environmental agency)